A mild hydrolysis of esters mediated by lithium salts
摘要:
When treated with amine bases such as triethylamine and various lithium salts in wet solvents, esters are efficiently hydrolyzed to the corresponding acids in good yields. Esters incorporating an alpha- or beta-heteroatom with respect to the ester carbonyl group are hydrolyzed rapidly even at room temperature. To further demonstrate the usefulness of this method, one example is provided where hydrolysis of acetylated camphorsultam is mediated by LiBr. (c) 2007 Elsevier Ltd. All riehts reserved.
Intermediates for the synthesis of epothilones and methods for their preparation
申请人:Novartis AG
公开号:US06350878B1
公开(公告)日:2002-02-26
The invention relates to a method of synthesis for a compound of formula (I),
wherein R is a heterocyclyl moiety and X1, X2, X3 and X4 are, independently of each other, protecting groups, which is appropriate for the synthesis of epothilone B and desoxyepothione B.
[EN] PROCESS FOR IXABEPILONE, AND INTERMEDIATES THEREOF<br/>[FR] PROCÉDÉ DE FABRICATION D'IXABÉPILONE, ET PRODUITS INTERMÉDIAIRES DE CELUI-CI
申请人:SCINOPHARM TAIWAN LTD
公开号:WO2014136099A1
公开(公告)日:2014-09-12
The present invention relates to a novel process of making ixabepilone, ixabepilone derivatives and analogues, and intermediates thereof.
本发明涉及一种制备伊西贝铂、伊西贝铂衍生物和类似物及其中间体的新工艺。
PEPTIDOMIMETIC PROTEASE INHIBITORS
申请人:Vertex Pharmaceuticals Incorporated
公开号:US20140294763A1
公开(公告)日:2014-10-02
The present invention relates to peptidomimetic compounds useful as protease inhibitors, particularly as serine protease inhibitors and more particularly as hepatitis C NS3 protease inhibitors; intermediates thereto; their preparation including novel steroselective processes to intermediates. The invention is also directed to pharmaceutical compositions and to methods for using the compounds for inhibiting HCV protease or treating a patient suffering from an HCV infection or physiological condition related to the infection. Also provided are pharmaceutical combinations comprising, in addition to one or more HCV serine protease inhibitors, one or more interferons exhibiting anti-HCV activity and/or one or more compounds having anti HCV activity and a pharmaceutically acceptable carrier, and methods for treating or preventing a HCV infection in a patient using the compositions. The present invention is also directed to a kit or pharmaceutical pack for treating or preventing HCV infection in a patient.
PROCESS FOR IXABEPILONE, AND INTERMEDIATES THEREOF
申请人:ScinoPharm Taiwan, Ltd.
公开号:EP2964645B1
公开(公告)日:2018-07-11
PROCESS FOR THE PREPARATION OF EPOTHILONES
申请人:Chen Yue
公开号:US20080319211A1
公开(公告)日:2008-12-25
Intermediates in the preparation of epothilones and epothilone analogs are provided along with synthetic methods useful in the synthesis of epothilone compounds.